DNA stability and serum selenium levels in a high-risk group for prostate cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 13, Issue 3, 2004, Pages 391-397

  Karunasinghe, Nishi ^a   Ryan, Jacqueline ^b   Tuckey, John ^b   Masters, Jonathan ^b   Jamieson, Michael ^c   Clarke, Larry C ^e   Marshall, James R ^d   Ferguson, Lynnette R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c WAIKATO HOSPITAL   (New Zealand)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

DNA; GLUTATHIONE PEROXIDASE; PLACEBO; PROSTATE SPECIFIC ANTIGEN; SELENIUM; SELENO EXCELL; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CLINICAL TRIAL; COMET ASSAY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DEGENERATIVE DISEASE; DIETARY INTAKE; DNA DAMAGE; DNA REPAIR; DOUBLE BLIND PROCEDURE; FOLLOW UP; FOOD COMPOSITION; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKOCYTE; MALE; MOLECULAR STABILITY; NEW ZEALAND; OXIDATIVE STRESS; PARAMETER; PATIENT MONITORING; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; REFERENCE VALUE; RELIABILITY; STATISTICAL ANALYSIS; SUPPLEMENTATION; TABLET; TRACE METAL BLOOD LEVEL; BLOOD; COHORT ANALYSIS; DIET; DIET SUPPLEMENTATION; GENETICS; MIDDLE AGED; PROSTATE TUMOR; RISK FACTOR;

AGED; COHORT STUDIES; COMET ASSAY; DIET; DIETARY SUPPLEMENTS; DNA DAMAGE; DNA REPAIR; GLUTATHIONE PEROXIDASE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RISK FACTORS; SELENIUM; TUMOR MARKERS, BIOLOGICAL;

EID: 2342474324     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Thomson CD, Rea HM, Doesburg VM, Robinson MF. Selenium concentrations and glutathione peroxidase activities in whole blood of New Zealand residents. Br J Nutr, 1977;37:457-60.
2. Thomson CD, Robinson MF. The changing selenium status of New Zealand residents. Eur J Clin Nutr, 1996;50:107-14.
3. Yang GQ, Wang SZ, Zhou RH, Sun SZ. Endemic selenium intoxication of humans in China. Am J Clin Nutr, 1983;37:872-81.
4. Brown KM, Arthur JR. Selenium, selenoproteins and human health: a review. Public Health Nutr, 2001;4(2B):593-9.
5. El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mutat Res, 2001;475(1,2):123-40.
6. Combs GF Jr. Should intakes with beneficial actions, often requiring supplementation, be considered for RDAs? J Nutr, 1996;126(9 Suppl):2373S-6S.
7. Schrauzer GN, White DA, Schneider CJ. Cancer mortality correlation studies. III: Statistical associations with dietary selenium intakes. Bioinorg Chem, 1977;7:23-31.
8. Yoshizawa K, Willett WC, Morris SJ, et al. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst, 1998;90:1219-24.
9. Blot WJ, Li JY, Taylor PR, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst (USA), 1993;85:1483-92.
10. Clark LC, Combs GF Jr, Turnbull BW, et al. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 1996;276:1957-63.
11. Clark LC, Dalkin B, Krongrad A, et al. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol, 1998;81:730-4.
12. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin, 2000;50(1):7-33.
13. Fenech M, Ferguson LR. Vitamins/minerals and genomic stability in humans. Mutat Res, 2001;475:1-7.
14. Burcham PC. Internal hazards: baseline DNA damage by endogenous products of normal metabolism. Mutat Res, 1999;443:11-36.
15. Ferguson LR. Natural and human-made mutagens and carcinogens in the human diet. Toxicology, 2002;181-182C:79-82.
16. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet, 2001;357:539-45.
17. Fleming J, Ghose A, Harrison PR. Molecular mechanisms of cancer prevention by selenium compounds. Nutr Cancer, 2001;40:42-9.
18. Witte KK, Clarke AL, Cleland JG. Chronic heart failure and micronutrients. J Am Coll Cardiol, 2001;37:1765-74.
19. Rayman MP. Review-the importance of selenium to human health. Lancet, 2000;356:233-41.
20. Thomson CD, Robinson MF, Butler JA, Whanger PD. Long term supplementation with selenate and selenomethionine: selenium and glutathione peroxidase (EC 1.11.1.9) in blood components of New Zealand women. Br J Nutr, 1993;69:577-88.
21. Boccon-Gibod L. Rising PSA with a negative biopsy. Eur Urol, 2001;40 Suppl 2:3-8.
22. Collins AR, Horvathova E. Oxidative DNA damage, antioxidants and DNA repair: applications of the comet assay. Biochem Soc Trans, 2001;29(Pt 2):337-41.
23. Hershey JW, Oostdyk TS. Determination of arsenic and selenium in environmental and agricultural samples by hydride generation atomic absorption spectrometry. J Assoc Off Anal Chem, 1988;71(6):1090-3.
24. Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantification of low levels of DNA damage in individual cells. Exp Cell Res, 1988;175:184-91.
25. Gedik CM, Boyle SP, Wood SG, Vaughan NJ, Collins AR. Oxidative stress in humans: validation of biomarkers of DNA damage. Carcinogenesis, 2002;23:1441-6.
26. Collins AR, Dusinska M, Horska A. Detection of alkylation damage in human lymphocyte DNA with the comet assay. Acta Biochim Pol, 2001;48:611-4.
27. Collins AR, Dusinska M, Horvathova E, Munro E, Savio M, Stetina R. Inter-individual differences in repair of DNA base oxidation, measured in vitro with the comet assay. Mutagenesis, 2001;16:297-301.
28. Collins A, Dusinska M, Franklin M, et al. Comet assay in human biomonitoring studies: reliability, validation, and applications. Environ Mol Mutagen, 1997;30:139-46.
29. Monfared AS, Mozdarani H. Synergistic effects of laserthermia and bleomycin-sulphate on micronuclei formation in cytokinesis-blocked HeLa cells. Irn J Med Sci, 1999;24:87-91.
30. Duthie SJ, Ma A, Ross MA, Collins AR. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes. Cancer Res, 1996;56:1291-5.
31. Littell RC, Milliken GA, Stroup WW, Wolfinger RD. SAS system for mixed models. Cary, NC: SAS Institute; 1996.
32. Winterbourn CC, Saville DJ, George PM, Walmsley TA. Increase in selenium status of Christchurch adults associated with deregulation of wheat market. New Zealand Med J, 1992;105:466-8.
33. Robinson MF, Godfrey PJ, Thomson CD, Rea HM, van Rij AM. Blood selenium and glutathione peroxidase activity in normal subjects and in surgical patients with and without cancer in New Zealand. Am J Clin Nutr, 1979;32:1477-85.
34. Robinson MF, Campbell DR, Stewart RD, et al. Effect of daily supplementation on patients with muscular complaints in Otago and Canterbury. New Zealand Med J, 1981;93:289-92.
35. Thomson CD, Steven SM, van Rij AM, Wade CR, Robinson MF. The effect of supplementation with selenium and α tocopherol on activities of glutathione peroxidase and related enzymes in human tissue. Am J Clin Nutr, 1996;48:316-23.
36. Robinson MF, Thomson CD, Jenkinson CP, Luzhen G, Whanger PD. Long term supplementation with selenate and selenomethionine: urinary excretion by New Zealand women. Br J Nutr, 1997;77:551-63.
37. Duffield AJ, Thomson CD. A comparison of methods of assessment of dietary selenium intakes in Otago, New Zealand. Br J Nutr, 1999;82:131-40.
38. de Jong N, Gibson RS, Thomson CD, et al. Selenium and zinc status are suboptimal in a sample of older New Zealand women in a community-based study. J Nutr, 2001;131:2677-84.
39. Kay RG, Knight GS. Blood selenium in an adult Auckland population group. New Zealand Med J, 1979;90:11-3.
40. Beaglehole R, Jackson R, Watkinson J, Scragg R, Yee RL. Decreased blood selenium and risk of myocardial infarction. Int J Epidemiol, 1990;19:918-22.
41. Ursini F, Bindoli A. The role of selenium peroxidases in the protection against oxidative damage of membranes. Chem Phys Lipids, 1987;44:255-76.
42. Ursini F, Maiorino M, Gregolin C. The selenoenzyme phospholipid hydroperoxide glutathione peroxidase. Biochim Biophys Acta, 1985;839:62-70.
43. Takahashi K, Avissar N, Whitin J, Cohen H. Purification and characterization of human plasma glutathione peroxidase: a selenoglycoprotein distinct from the known cellular enzyme. Arch Biochem Biophys, 1987;256:677-86.
44. Chu FF, Doroshow JH, Esworthy RS. Expression, characterization and tissue distribution of a new cellular selenium dependent glutathione peroxidase. GSHPx-GI. J Biol Chem, 1993;268:2571-6.
45. Mustacich D, Powis G. Thioredoxin reductase. Biochem J, 2000;346 (Pt 1):1-8.
46. Mostert V. Selenoprotein P: properties, functions, and regulation. Arch Biochem Biophys, 2000;376:433-8.
47. Vendeland SC, Beilstein MA, Chen CL, Jensen ON, Barofsky E, Whanger PD. Purification and properties of selenoprotein W from rat muscle. J Biol Chem, 1993;268:17103-7.
48. Behne D, Kyriakopoulos A, Kalcklosch M, et al. Two new selenoproteins found in the prostatic glandular epithelium and in the spermatid nuclei. Biomed Environ Sci, 1997;10:340-5.
49. Sunde RA, Thompson BM, Palm MD, Weiss SL, Thompson KM, Evenson JK. Selenium regulation of selenium-dependent glutathione peroxidases in animals and transfected CHO cells. Biomed Environ Sci, 1997;10:346-55.
50. Levander OA, Whanger PD. Deliberations and evaluations of the approaches, endpoints and paradigms for selenium and iodine dietary recommendations. J Nutr, 1996;126(9 Suppl):2427S-34S.
51. Duffield AJ, Thomson CD, Hill KE, Williams S. An estimation of selenium requirements for New Zealanders. Am J Clin Nutr, 1999;70:896-903.
52. Alfthan G, Aro A, Arvilommi H, Huttunen JK. Selenium metabolism and platelet glutathione peroxidase activity in healthy Finnish men: effect of selenium yeast, selenite and selenate. Am J Clin Nutr, 1991;53:120-5.
53. Fischer A, Pallauf J, Gohil K, Weber SU, Packer L, Rimbach G. Effect of selenium and vitamin E deficiency on differential gene expression in rat liver. Biochem Biophys Res Commun, 2001;285:470-5.